Monopar Therapeutics Inc. (MNPR) short interest & options flow
NASDAQMNPR heads into tomorrow's August 14 print with analyst conviction building and a short position that has shed nearly 40% of its mass in a month — yet enough residual bears remain to make this a genuine binary event. The analyst backdrop has turned more constructive than at any point this year. BTIG raised its price target to $133 yesterday — the day before earnings — maintaining…
MNPR short interest plunged 20.5% over the past week to 14.5% of float, marking the steepest decline in two months as availability surged to 114% — well above the 52-week average of 72%.
- Market cap
- $495M
- Next earnings
- 17 Nov 2026
Key data as of 10 Nov 2026
Latest signals on MNPR
- Short Interest
MNPR short interest plunged 20.5% over the past week to 14.5% of float, marking the steepest decline in two months as availability surged to 114% — well above the 52-week average of 72%.
MNPR news and analysis
RSSNo long-form analysis yet for MNPR. Pulse alerts and the live data picture are available on ORTEX.
Open MNPR on ORTEX →Want the live picture for MNPR?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MNPR — free to start on ORTEX.
Sign up for free →Open MNPR on ORTEX